Don't get left behind! The modernized ClinicalTrials.gov is coming. Check it out now.
Say goodbye to ClinicalTrials.gov!
The new site is coming soon - go to the modernized ClinicalTrials.gov
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Trametinib in Treating Patients With Relapsed or Refractory Juvenile Myelomonocytic Leukemia

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03190915
Recruitment Status : Active, not recruiting
First Posted : June 19, 2017
Last Update Posted : May 11, 2023
Sponsor:
Collaborator:
Children's Oncology Group
Information provided by (Responsible Party):
National Cancer Institute (NCI)

No Study Results Posted on ClinicalTrials.gov for this Study
About Study Results Reporting on ClinicalTrials.gov
Recruitment Status : Active, not recruiting
Actual Primary Completion Date : March 31, 2023
Estimated Study Completion Date : May 8, 2024
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):